ACHC
Acadia Healthcare Company, Inc.Marquee-fund ownership over time
This quarter's activity
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Maverick Capital re-entered | Q3 2014 | 48Q | $49 | $24 | -50% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $73 | $24 | -66% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $73 | $24 | -66% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $73 | $24 | -66% |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $73 | $24 | -66% |
| Two Sigma Investments re-entered | Q1 2025(8Q snapshot) | 5Q | $41 | $24 | -41% |
| AQR Capital Management | Q3 2025(8Q snapshot) | 3Q | $21 | $24 | +18% |
| Soros Fund Management | Q2 2026(8Q snapshot) | 1Q | $26 | $24 | -5% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 2× in & out | Q4 2025 | Q2 2026 | → $26 | +61% |
| Viking Global Investors 2× in & out | Q1 2021 | Q1 2025 | → $41 | -21% |
| Elliott Management | Q1 2019 | Q2 2020 | → $25 | -9% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Acadia Healthcare Company, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 8, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-215070May 8, 2026
- Form 40001193125-26-214932May 8, 2026
- Form 40001193125-26-214931May 8, 2026
- Form 40001193125-26-214930May 8, 2026
- Form 40001193125-26-214929May 8, 2026
- Form 40001193125-26-214927May 8, 2026
- Form 40001193125-26-214926May 8, 2026
- Form 40001193125-26-214925May 8, 2026
- Form 40001193125-26-214924May 8, 2026
- Form 40001193125-26-209423May 6, 2026
- Form 40001193125-26-198070Apr 30, 2026
- Form 40001193125-26-153040Apr 13, 2026
- Form 40001193125-26-153039Apr 13, 2026
- Form 40001193125-26-114519Mar 18, 2026
- Form 40001193125-26-083110Feb 27, 2026
Fundamentals
XBRL · Acadia Healthcare Company, Inc.Annual figures sourced directly from Acadia Healthcare Company, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Acadia Healthcare Company, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 18, 2026
- 8-KMaterial eventMay 6, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KFORM 8-KApr 29, 2026
- 8-KMaterial eventApr 23, 2026
- DEF 14AProxy statementMar 25, 2026
- 8-KMaterial eventMar 12, 2026
- 10-KAnnual reportFeb 27, 2026
- 8-KFORM 8-KFeb 25, 2026
- 8-KMaterial eventJan 23, 2026
- 8-KFORM 8-KJan 20, 2026
- 8-KFORM 8-KJan 13, 2026
- 8-KFORM 8-KDec 2, 2025
- 8-KMaterial eventNov 10, 2025
- 10-QQuarterly reportNov 5, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Soros Fund Management | Q2 2026 | open | $26 | $25 | -2% |
| Point72 Asset Management | Q2 2026 | open | $26 | $25 | -2% |
| Two Sigma Investments | Q1 2026 | open | $16 | $25 | +54% |
| Citadel Advisors | Q4 2025 | open | $16 | $25 | +58% |
| Bridgewater Associates | Q4 2025 | Q2 2026 | $16 | $26 | +61% |
| AQR Capital Management | Q3 2025 | open | $21 | $25 | +23% |
| Two Sigma Investments | Q1 2025 | Q4 2025 | $41 | $16 | -61% |
| Maverick Capital | Q1 2025 | open | $41 | $24 | -41% |
| Citadel Advisors | Q3 2024 | Q3 2025 | $73 | $21 | -72% |
| D.E. Shaw | Q3 2024 | open | $73 | $25 | -65% |
| Millennium Management | Q3 2024 | open | $73 | $25 | -65% |
| Point72 Asset Management | Q3 2024 | Q2 2025 | $73 | $26 | -65% |
| Maverick Capital | Q2 2024 | Q3 2024 | $69 | $73 | +6% |
| Bridgewater Associates | Q4 2021 | Q2 2025 | $65 | $26 | -60% |
| Maverick Capital | Q2 2021 | Q4 2021 | $64 | $65 | +2% |
| Viking Global Investors | Q1 2021 | Q1 2025 | $52 | $41 | -21% |
| Maverick Capital | Q2 2020 | Q1 2021 | $25 | $52 | +111% |
| Maverick Capital | Q4 2019 | Q1 2020 | $31 | $34 | +9% |
| Elliott Management | Q1 2019 | Q2 2020 | $27 | $25 | -9% |
| Maverick Capital | Q4 2018 | Q3 2019 | $37 | $28 | -26% |
| Maverick Capital | Q2 2018 | Q3 2018 | $42 | $39 | -6% |
| Viking Global Investors | Q2 2017 | Q3 2017 | $44 | $52 | +19% |
| Maverick Capital | Q3 2014 | Q4 2014 | $49 | $61 | +25% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.